Chapter 4. Epidemiology and Screening for Chronic Kidney Disease

  1. Donald A. Molony MD2,3 and
  2. Jonathan C. Craig MD, PhD4,5
  1. Sylvia Paz B. Ramirez MD, MPH, MBA

Published Online: 4 MAR 2009

DOI: 10.1002/9781444303391.ch4

Evidence-Based Nephrology

Evidence-Based Nephrology

How to Cite

Ramirez, S. P. B. (2008) Epidemiology and Screening for Chronic Kidney Disease, in Evidence-Based Nephrology (eds D. A. Molony and J. C. Craig), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444303391.ch4

Editor Information

  1. 2

    Division of Renal Disease and Hypertension, University of Texas, USA

  2. 3

    Houston Medical School, Houston, Texas, USA

  3. 4

    School of Public Health, University of Sydney, Australia

  4. 5

    Department of Nephrology, The Children's Hospital at Westmead, Sydney, Australia

Author Information

  1. Arbor Research Collaborative for Health, Ann Arbor, USA

Publication History

  1. Published Online: 4 MAR 2009
  2. Published Print: 5 DEC 2008

ISBN Information

Print ISBN: 9781405139755

Online ISBN: 9781444303391



  • screening for chronic kidney disease;
  • Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines;
  • high-risk populations for CKD;
  • cardiovascular disease;
  • angiotensin converting enzyme inhibitor (ACEi);
  • hypertension and cardiovascular disease as risk factors for CKD;
  • race and ethnicity;
  • family history;
  • nondiabetic nephropathy


This chapter contains sections titled:

  • Epidemiology of chronic kidney disease as a basis for a population-based system for surveillance and screening for kidney disease

  • Impact of natural history of CKD on screening

  • Impact of other factors on development of a surveillance and screening system

  • High-risk populations for CKD

  • Cost-effectiveness analyses for CKD screening

  • Discussion and recommendations for future research

  • References